Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKOAP: Sequenced Strategy for Improving Outcomes in Knee Osteoarthritis Pain
NCT04504812Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2021
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in knee osteoarthritis (OA), sponsored by Johns Hopkins University. Started Feb 2021; status: completed.
02
Drugs
duloxetine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04504812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04504812.